Drug Type Small molecule drug |
Synonyms KS-217, NN-818 |
Target |
Action modulators |
Mechanism APP modulators(Beta amyloid A4 protein modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Parkinson Disease | Preclinical | United States | - | |
| Brain Injuries | Discovery | United States | - |





